Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

5.080 -0.340 (-6.27%)
Streaming Delayed Price Updated: 12:07 PM EDT, May 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CNS Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
23 24 Next >
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
CNS Pharmaceuticals Stock Was Volatile Wednesday: What You Need To Know ↗
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) experienced significant movement in its share price Wednesday afternoon. Here's a look at what happened. 
Via Benzinga
News headline image
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
Brain Cancer in Kids Could Soon Be Detected by 10-Minute Scan
Via Investor Brand Network
News headline image
How Is The Market Feeling About CNS Pharma? ↗
 
Via Benzinga
News headline image
Why CNS Pharmaceuticals Shares Are Getting Hammered ↗
CNS Pharmaceuticals shares are trading lower by 33.4% during Monday's session. The company announced a 1-for-50 reverse split of its common stock. 
Via Benzinga
News headline image
CNS Pharmaceuticals to Present at Alliance Global Partner's 2024 Healthcare Company Showcase
Via ACCESSWIRE
TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Pricing of Registered Direct, Concurrent Private Placement
Via Investor Brand Network
News headline image
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc.(NASDAQ: CNSP) Enters in Purchase Agreements, Announces Pricing
Via Investor Brand Network
News headline image
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
CNS Pharmaceuticals Announces Pricing of Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Reverse Stock Split
Via Investor Brand Network
News headline image
Dow Dips Over 300 Points; GameStop Shares Spike Higher ↗
 
Via Benzinga
Topics Stocks
News headline image
Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Down Over 3%; US Construction Spending Falls In May ↗
 
Via Benzinga
Virginia Tech Clinical Trial Seeks End to Brain Cancer Surgery
Via Investor Brand Network
News headline image
Nasdaq Surges 150 Points; US Manufacturing PMI Rises In May ↗
 
Via Benzinga
News headline image
CNS Pharmaceuticals Announces Reverse Stock Split
Via ACCESSWIRE
BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at 2024 Healthcare Company Showcase
Via Investor Brand Network
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Q1 2024 Financial, Business Report
Via Investor Brand Network
News headline image
CNSP Stock Earnings: CNS Pharmaceuticals Reported Results for Q1 2024 ↗
CNS Pharmaceuticals just reported results for the first quarter of 2024. 
Via InvestorPlace
News headline image
CNS Pharmaceuticals Reports First Quarter 2024 Financial Results
Via ACCESSWIRE
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.